News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
Johnson & Johnson (JNJ) To Webcast Annual Meeting Of Shareholders 3/27/2015
Valeant (VRX) Closes Offering Of $1.45 Billion Of Common Shares 3/27/2015
Synergy Pharmaceuticals May Be for Sale 3/27/2015
Analyst: First Quarter Market Meltdown Just "Clockwork," As Biogen (BIIB), Celgene (CELG) Reign 3/27/2015
SurePure Completes Verification And Approved For Trading On The OTCQB Marketplace 3/27/2015
Galapagos (GLPG.BR) Release: Publication Of Annual Report 2014 And Invitation To The Annual Shareholders' Meeting To Be Held On 28 April 2015 3/27/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company 3/27/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/27/2015
Conatus Pharma Shares Soar On Successful Emricasan Phase II Results 3/26/2015
Early-Stage Biotech Star Flagship Ventures Scores $537M for New Fund 3/26/2015
Why Your Last Investment Blew Up 3/26/2015
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 3/26/2015
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 3/26/2015
Notice Of Annual General Meeting In Biotage AB (BIOTa.ST) (Publ) 3/26/2015
Becton, Dickinson and Company (BDX) To Commence Exchange Offers 3/26/2015
Novavax, Inc. (NVAX) Prices Public Offering Of Common Stock 3/26/2015
Sucampo Pharmaceuticals, Inc. (SCMP) Prices Public Offering Of Common Stock By Selling Stockholders 3/26/2015
SteadyMed (STDY) Announces Closing of Initial Public Offering 3/26/2015
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Proposed Public Offering By Selling Stockholders 3/26/2015
Cardica, Inc. (CRDC) To Host Business Update Conference Call 3/26/2015
Omnicell Receives Expected Nasdaq Notification Of Noncompliance 3/25/2015
Haemonetics Corporation (HAE) Sets Date For Investor/Analyst Meeting - May 19, 2015 3/25/2015
ZS Pharma (ZSPH) Announces Upsizing And Pricing Of $186 Million Public Offering Of Common Stock 3/25/2015
Novavax, Inc. (NVAX) Announces Proposed Public Offering Of Common Stock 3/25/2015
Oxis Biotech Inc. Announces Corporate Update Conference Call For March 31 3/25/2015
EPIRUS Biopharmaceuticals To Host Biosimilar Key Opinion Leader Meeting And Webcast On March 30 3/25/2015
Nasdaq Welcomes Cellectis (ALCLS) The Nasdaq Stock Market 3/25/2015
Tekmira (TKMR) Announces Completion Of Underwritten Public Offering Of Common Shares 3/25/2015
Notice of General Meeting In Probi AB (publ) 3/25/2015
Nolato AB ( NOLA-B.ST): Notice Of The 2015 Annual General Meeting 3/25/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/25/2015
Cellectis (ALCLS) Prices Initial Public Offering Of American Depositary Shares 3/25/2015
Merck & Co. (MRK) Announces New $10 Billion Share Repurchase Program 3/25/2015
Retrophin (RTRX) Closes Public Offering Of 7,866,000 Shares Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares 3/25/2015
Concert Pharmaceuticals, Inc. (CNCE) Announces Completion Of Public Offering 3/25/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/25/2015
Buy This Stock to Bet on Biogen (BIIB) Drug, Says Raymond James & Associates 3/24/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion Of Public Offering Of Common Stock 3/24/2015
Blueprint Medicines Files Registration Statement for Proposed Initial Public Offering 3/24/2015
ZS Pharma (ZSPH) Announces Proposed Public Offering Of Common Stock 3/24/2015
InVivo Therapeutics Corporation (NVIV) Announces Reverse Stock Split In Preparation For Planned Uplisting To NASDAQ 3/24/2015
Pfizer (PFE) Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts 3/24/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/24/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY) 3/23/2015
Lpath, Inc. (LPTN) To Hold Investor Update Conference Call 3/23/2015
Capstone Therapeutics (CAPS) Announces Operating Update Conference Call 3/23/2015
Convening Notice For 2015 Annual General Meeting In Precise Biometrics AB (Publ) 3/23/2015
Notice Of Annual General Meeting In Bioinvent International AB 3/23/2015
AtriCure, Inc. (ATRC) To Ring The Nasdaq Stock Market Closing Bell 3/23/2015
Sterigenics International, Inc. Announces Recapitalization With Warburg Pincus And GTCR 3/23/2015
OXiGENE (OXGN) Announces $10 Million At-the-Market Registered Direct Offering 3/20/2015
Tekmira (TKMR) Announces Pricing Of Underwritten Public Offering Of Common Shares 3/20/2015
TiGenix: Convening Notice To The Annual And The Extraordinary Shareholders' Meeting To Be Held On 20 April 2015 3/20/2015
CorMedix (CRMD) Announces Effectiveness Of Registration Statements For Shares Underlying Publicly Traded Warrants 3/20/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/20/2015
Tekla Life Sciences Investors Announce Renewal Of Share Repurchase Program 3/20/2015
SciClone Pharmaceuticals, Inc. (SCLN) To Present At Investor And Partnering Conferences In China 3/20/2015
Theravance (THRX) Announces Trading In Common Stock Halted 3/20/2015
Retrophin (RTRX) Prices Public Offering Of 6,840,000 Shares Of Common Stock 3/19/2015
Agilent Technologies Inc. (A) Announces Cash Dividend Of 10 Cents Per Share 3/19/2015
Concert Pharmaceuticals, Inc. (CNCE) Announces Proposed Public Offering Of Common Stock 3/19/2015
Assembly Biosciences Announces Pricing Of $75 Million Public Offering Of Its Common Stock 3/19/2015
Summit Therapeutics Announces Exercise of Over-Allotment Option 3/19/2015
Tekmira (TKMR) Announces Proposed Public Offering Of Common Shares 3/19/2015
Assembly Biosciences Announces Proposed Public Offering Of Common Stock 3/19/2015
Galena Biopharma  (GALE) Announces Closing Of Public Offering Of Common Stock And Warrants 3/19/2015
Intellect Neurosciences, Inc. Issues Letter To Shareholders 3/19/2015
Esperion Therapeutics (ESPR) Prices Public Offering Of Common Stock 3/19/2015
Resolutions From The Annual General Meeting Of Novo Nordisk A/S (NVO) 3/19/2015
Rhinomed (ASX:RNO) Investor Newsletter 3/19/2015
Concert Pharmaceuticals, Inc. (CNCE) Announces Pricing Of Public Offering 3/19/2015
Juno Therapeutics (JUNO) Post IPO: Ups and Downs But Mostly Ups 3/18/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Proposed Public Offering Of Common Stock 3/18/2015
TetraPhase Pharmaceuticals (TTPH) Announces Closing Of Public Offering Of Common Stock 3/18/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Pricing Of Public Offering Of Common Stock 3/18/2015
Lixte Biotechnology Completes Private Placement Of Convertible Preferred Stock 3/18/2015
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 3/18/2015
Avalanche Biotechnologies (AAVL) To Host Analyst And Investor Day On March 25, 2015 3/18/2015
BioMarin (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/18/2015
Celator Pharmaceuticals, Inc. Announces Business Update And Fourth Quarter And Full Year 2014 Financial Results 3/18/2015
Esperion Therapeutics (ESPR) Announces Proposed Public Offering Of Common Stock 3/18/2015
Admedus Announces Placement And Rights Issue 3/18/2015
ADMA Biologics, Inc. Announces Closing Of Public Offering Of Common Stock And Exercise Of Over-Allotment Option In Full 3/18/2015
Election Of New Board Members By Extraordinary General Meeting Of Cortendo AB 3/18/2015
Omnicell Provides Update On Form 10-K Filing And Reaffirms 2015 Financial Guidance 3/18/2015
MS Specialist Picks Biogen Idec (BIIB)’s Tecfidera and Plegridy, Teva (TEVA)’s Laquinimod: Analyst 3/17/2015
Epizyme (EPZM) Eyes $100 Million for Mid-Stage Trials of a Reacquired Drug 3/17/2015
Johnson & Johnson (JNJ) Announces Strategic Investment Alliance To Combat Dementia Globally 3/17/2015
Valeant (VRX) Prices Offering Of $1.45 Billion Of Common Shares 3/17/2015
Kythera (KYTH) Announces Closing Of Public Offering And Exercise Of Underwriters' Over-Allotment Option 3/17/2015
Bellerophon Therapeutics (BLPH) To Ring The NASDAQ Stock Market Closing Bell 3/17/2015
Heat Biologics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of The Underwriters' Over-Allotment Option 3/17/2015
Genocea Biosciences Announces Closing Of $51.7 Million Public Offering Of Common Stock And Exercise In Full Of Underwriters’ Option To Purchase Additional Shares 3/17/2015
Valeant (VRX) Announces Offering Of $1.45 Billion Of Common Shares 3/17/2015
BioDelivery Sciences International (BDSI) Provides Corporate Update And Reports Fourth Quarter And Year-End 2014 Financial Results 3/17/2015
Eagle Pharmaceuticals (EGRX) Announces Pricing Of Public Offering Of Common Stock 3/17/2015
OncoSec Medical Inc. CEO Punit Dhillon To Host Live Webinar To Provide Corporate Update And 2015 Outlook 3/17/2015
Retrophin (RTRX) Announces Proposed Public Offering Of 5,100,000 Shares Of Common Stock 3/17/2015
Eagle Pharmaceuticals (EGRX) Announces Commencement Of Public Offering Of Common Stock 3/17/2015
Horizon Pharma plc.  (HZNP) Closes Offering Of $400 Million Of 2.50% Exchangeable Senior Notes, Including Exercise In Full Of Option To Purchase Additional Notes 3/17/2015
Oculus Innovative Sciences, Inc. (OCLS) Announces Sale Of 350,000 Shares Of Ruthigen Stock For $962,500 In Non-Dilutive Funding 3/16/2015
Polar Capital Funds Plc And Fmr Llc Provide Notification Of Shareholding In Ablynx (ABLYF) 3/16/2015
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/16/2015
IMS Health Announces Offering Of Senior Notes To Finance Proposed Acquisition Of Cegedim SA’s CRM And Strategic Data Businesses 3/16/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 3/16/2015
Oxford BioMedica PLC (OXB.L) Director's Share Purchase 3/16/2015
Notice of Annual General Meeting Of Orexo AB (ORXOF) 3/16/2015
Ablynx (ABLYF) Announces Warrant Exercise 3/16/2015
Washington State Court Issues Order Requiring Acucela To Hold Special Shareholders Meeting 3/16/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS 3/16/2015
Depomed, Inc. (DEPO) Nabs $575 Million Debt Facility From Deerfield, Pharmakon Advisors 3/13/2015
ThromboGenics NV (TBGNF) Full Year 2014 Business Update 3/13/2015
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 3/13/2015
Galena Biopharma  (GALE) Announces Proposed Public Offering Of Common Stock And Warrants 3/13/2015
ADMA Biologics, Inc. Announces Proposed Public Offering Of Common Stock 3/13/2015
Galena Biopharma  (GALE) Announces Pricing Of Public Offering Of Common Stock And Warrants 3/13/2015
Replicel Life Sciences In Japan For Key Industry Meetings 3/12/2015
TetraPhase Pharmaceuticals (TTPH) Announces Pricing Of Public Offering Of Common Stock 3/12/2015
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise And Projection Of Improved Cash Position At The End Of 2015 3/12/2015
Intra-Cellular Therapies, Inc. Announces Closing Of $130 Million Public Offering Including Exercise Of Underwriters' Option To Purchase Additional Shares 3/12/2015
Raptor Pharmaceutical Inc. (RPTP) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/12/2015
Genocea Biosciences Announces Pricing Of $45 Million Public Offering 3/12/2015
Acucela Files Opposition To SBI/Kubota Motion To Compel Company To Call Special Shareholders Meeting 3/12/2015
Champions Oncology, Inc. (CSBR) Announces $14 Million Capital Raise 3/12/2015
Mylan N.V. And Mylan Inc. (MYL) Announce Successful Completion Of Consent Solicitations For Mylan Inc.'s Notes 3/12/2015
Medivir AB (MVRBF) Capital Markets Meeting On 26 March 2015 3/12/2015
Actavis (ACT) Announces Closing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/12/2015
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 3/12/2015
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 3/11/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 3/11/2015
Heat Biologics Announces Proposed Public Offering Of Common Stock 3/11/2015
Heat Biologics Announces Pricing Of Public Offering Of $10,660,000 Of Common Stock 3/11/2015
Kythera (KYTH) Announces Pricing Of Public Offering Of Common Stock 3/11/2015
Lonza Group Ltd. (LZAGY.PK) Publishes Annual Report 2014 And Invitation To The 2015 Annual General Meeting 3/11/2015
SYGNIS AG To Host Live Webinar On Its Revolutionary TrueprimeTechnology For Primer-Free Whole Genome Amplification (WGA) 3/11/2015
Aequus Pharmaceuticals Receives Conditional Approval To Commence Trading On TSX-V Exchange 3/11/2015
Auris Medical AG (EARS) To Host Key Opinion Leader Meeting On Tinnitus Treatments On March 13 In New York City 3/11/2015
CryoPort, Inc. Co-Sponsors The Alliance For Regenerative Medicine 3rd Annual REGENMED Investor Day 3/11/2015
Tenax Therapeutics (TENX) To Provide Corporate Update And Discuss Third Quarter Fiscal Year 2015 Financial Results On March 18, 2015 3/11/2015
BioLineRx Ltd. Closes $28.75 Million Underwritten Public Offering Of Its American Depositary Shares 3/11/2015
Actavis (ACT) And Allergan (AGN) Shareholders Approve Proposals Related To Actavis' Planned Acquisition Of Allergan 3/11/2015
AEterna Zentaris (AEZS) Announces Closing Of US$37 Million Public Offering Of Common Shares And Warrants 3/11/2015
Valeant (VRX) Announces Launch Of Private Offering Of Senior Notes 3/10/2015
HEALTHSOUTH Announces Pricing Of $300 Million Senior Notes Offering 3/10/2015
TetraPhase Pharmaceuticals (TTPH) Announces Proposed Public Offering Of Common Stock 3/10/2015
Tesaro, Inc. (TSRO) Announces Closing Of Public Offering Of Common Stock And Exercise Of Over-Allotment Option By Underwriters 3/10/2015
Kythera (KYTH) Announces Proposed Public Offering Of Common Stock 3/10/2015
Portola Pharmaceuticals, Inc. Announces Proposed Offering Of Common Stock 3/10/2015
Portola Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock 3/10/2015
PharmAthene, Inc. (PIP) Reports Year-End 2014 Financial And Operational Results; Announces Plan To Realign Operational Resources 3/10/2015
Opexa Therapeutics (OPXA) Reminds Shareholders That Rights Offering Ownership Date And Time Is Tuesday, March 10, 2015 At 4:00 PM ET 3/10/2015
Catalent, Inc. Closes Secondary Public Offering Of Common Stock 3/10/2015
NanoViricides, Inc. (NNVC.PK) Issued Registered Shares As Interest To Certain Debenture Holders 3/9/2015
Tobira Therapeutics Inc. Closes Financing To Support Development Of CVC In Non-Alcoholic Steatohepatitis 3/9/2015
HEALTHSOUTH Announces Launch Of $300 Million Senior Notes Offering Due 2023 And Intent To Redeem $290 Million Of Senior Notes Due 2020 3/9/2015
Flex Pharma (FLKS) Announces Establishment Of Stock Purchase Plan By Chief Executive Officer 3/9/2015
ProtoKinetix Inc. (PKTX.OB) Announces Settlement Of Debt 3/9/2015
Microbix Biosystems Inc. (MBXBF) Announces Annual And Special Meeting Voting Results 3/9/2015
Takeda Pharmaceutical Co. Ltd. (TKPYY) Hosts Investor Briefing On Its Global Leadership In Gastroenterology 3/9/2015
Horizon Pharma plc.  (HZNP) Prices Offering Of $350 Million Of 2.50% Exchangeable Senior Notes 3/9/2015
ProtoKinetix Inc. (PKTX.OB) Announces Share Issuance And Closing Of West Vancouver Office 3/9/2015
AEterna Zentaris (AEZS) Announces Proposed Public Offering Of Common Shares And Warrants 3/6/2015
DuPont (DD) Leader Highlights Strategy, Progress And Plans To Accelerate Growth In Advanced Materials And Discusses Near-Term Outlook 3/6/2015
BioLineRx Ltd. Announces Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
AEterna Zentaris (AEZS) Announces Pricing Of US$37 Million Public Offering Of Common Shares And Warrants 3/6/2015
BioLife Solutions, Inc. (BLFS.OB) To Report Fourth Quarter And Full Year 2014 Financial Results And Provide Business Update On March 12, 2015 3/6/2015
AmerisourceBergen Corporation (ABC) Announces Results Of Annual Meeting Of Stockholders 3/6/2015
BioLineRx Ltd. Prices $25 Million Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
Galapagos NV (GLPG.BR) To Be Included In Amsterdam Midcap Index 3/6/2015
PhytoTech Medical Limited (ASX:PYL) Investor Presentation 3/6/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst 3/6/2015
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib 3/5/2015
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 3/5/2015
KYTHERA Biopharmaceuticals, Inc. (KYTH) Grants Stock Options Under Inducement Program 3/5/2015
Summit Therapeutics To Ring The Nasdaq Stock Market Closing Bell 3/5/2015
PDL BioPharma, Inc. (PDLI) Announces Conversion Rate Adjustment For Convertible Note 3/5/2015
Tandem Diabetes Care Announces Closing Of Underwritten Public Offering Of Common Stock 3/5/2015
Nuvo Research Inc. (NRI.TO) Provides Business Update 3/5/2015
Capricor Therapeutics, Inc. Announces Uplisting To NASDAQ Capital Market 3/5/2015
ABC Laboratories, Inc. Announces Completion Of EPA GLP Audit 3/5/2015
Epizyme (EPZM) To Report Fourth Quarter 2014 Financial Results And Provide Corporate Update On March 12, 2015 3/5/2015
Horizon Pharma plc.  (HZNP) Announces Proposed Offering Of $300 Million Of Exchangeable Senior Notes 3/5/2015
Actavis (ACT) Announces Pricing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/4/2015
Lexicon Pharmaceuticals, Inc. (LXRX) Provides Clinical Pipeline Update And Reports 2014 Fourth Quarter And Full Year Financial Results 3/4/2015
AMAG Pharmaceuticals, Inc. (AMAG) Announces Closing Of $201 Million Public Offering Of Common Stock Including Full Exercise Of Underwriters' Option 3/4/2015
Relypsa, Inc. (RLYP) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares And Closing Of Public Offering Of Common Stock 3/4/2015
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Pricing Of Public Offering Of Common Stock 3/4/2015
Tesaro, Inc. (TSRO) Announces Pricing Of Public Offering Of Common Stock 3/4/2015
CorMedix (CRMD) Provides Multiple Strategic Business Updates 3/4/2015
Neovacs SA Scientific Advisory Board Endorses Company's Updated IFNa-Kinoid Development Plan 3/4/2015
Intra-Cellular Therapies, Inc. Announces Proposed Public Offering Of Common Stock 3/4/2015
GTx, Inc. (GTXI) Provides Corporate Update And Reports Fourth Quarter And Year-End 2014 Financial Results 3/4/2015
Acucela Inc. To Hold 2015 Annual Meeting Of Shareholders On June 8, 2015 3/4/2015
Cytori Therapeutics, Inc. (CYTX) Provides Business Update Along With Top-Line Unaudited 2014 Financial Results At The Cowen and Company 35th Annual Health Care Conference In Boston 3/4/2015
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel 3/3/2015
Actavis (ACT) Announces Closing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 3/3/2015
Xencor Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 3/3/2015
Lion Biotechnologies, Inc. Announces Closing Of Underwritten Public Offering Of Common Stock And Full Exercise Of The Underwriters' Option To Purchase Additional Shares 3/3/2015
Curis, Inc. (CRIS) Announces Closing Of Public Offering Of Common Stock 3/3/2015
Akorn, Inc. (AKN) Announces Filing Extension For Form 10-K 3/3/2015



//-->